Ophthalmic Lasers Market Size & Share 2025 - 2034

Ophthalmic Lasers Market Size

The global ophthalmic lasers market was valued at USD 1.8 billion in 2024. The market is expected to reach from USD 1.9 billion in 2025 to USD 3.1 billion in 2034, growing at a CAGR of 5.9% from 2025 to 2034, according to the latest report published by Global Market Insights Inc. The high market growth is attributed to the rising incidence of ophthalmic disorders, ongoing improvements in laser system technology, the rising popularity of outpatient procedures and minimally invasive surgery, and improved access to eye care in emerging economies, among other contributing factors.

Ophthalmic lasers are specialized medical instruments that use focused light energy to treat various eye conditions with high precision. They are used in cataract surgery, glaucoma, refractive error, and several retinal and vitreous disorders. Interventions needed within the eye are performed using specialized lasers, which are minimally invasive and enhance the patient’s recovery and visual outcomes.
 

Major companies in the ophthalmic lasers market are Alcon, Johnson & Johnson, ZEISS, LUMENIS, and NIDEK. These firms are known for their strong market presence and global competitiveness due to constant advancement in their product lines as well as high levels of research and development investment.
 

The market has increased from USD 1.6 billion in 2021 and reached USD 1.7 billion in 2023, with the historic growth rate of 5.1%. The adoption of femtosecond and YAG lasers in cataract and glaucoma surgeries as well as better reimbursement policies in developed markets are primary factors driving market growth. Further, the increasing number of outpatient surgical centers and the growing population of diabetics across the world further bolster sustained demand.
 

The increasing prevalence of eye diseases, including glaucoma, diabetic retinopathy, cataracts, and age-related macular degeneration, drives the demand for ophthalmic lasers. For instance, according to the World Health Organization (WHO), approximately 2.2 billion people globally had vision impairment in 2023, with 1 billion cases identified as preventable. Similarly, the International Diabetes Federation reported about 537 million adults aged 20-79 were living with diabetes in 2021, with projections of 643 million by 2024. The growing elderly population, anticipated to reach 1 billion people aged 65 and above by 2024 as per United Nations data, and increasing cases of diabetes contribute to higher patient volumes requiring laser-based eye procedures.
 

In addition, ophthalmic laser treatments are gaining popularity because they are less invasive than traditional surgical procedures. The American Society of Cataract and Refractive Surgery (ASCRS) stated that outpatient ophthalmic procedures grew by 35% from 2021 to 2023.
 

The Centers for Medicare and Medicaid Services also reported that about 92% of ophthalmic surgeries in 2023 were outpatient, an increase from 85% in 2021. These laser-assisted surgical procedures are reported to have faster recovery times and reduced complication rates. The U.S. FDA reported a 40% decrease in post-operative complications in laser-assisted over traditional surgeries in 2022.
 

Ophthalmic Lasers Market Trends

The ophthalmic lasers market is witnessing significant growth, driven by the surging shift toward femtosecond laser technology, integration of AI and imaging in laser systems, growing adoption of SLT for glaucoma treatment, rising demand for ambulatory surgical centers, and rise in customized and patient-centric laser treatments, among other factors are collectively boosting the industry growth.
 

• Femtosecond lasers are replacing conventional laser systems in cataract and refractive surgeries because of their precision and reduced tissue damage. According to the American Society of Cataract and Refractive Surgery (ASCRS), the adoption of femtosecond laser-assisted cataract surgery increased from 12% in 2021 to 19% in 2023. The U.S. FDA reported that femtosecond laser procedures for refractive surgeries grew by 23% between 2022 and 2023.
   
• These lasers enable bladeless incisions, making them essential for advanced eye surgeries. The European Society of Cataract and Refractive Surgeons (ESCRS) data shows that femtosecond laser-assisted procedures accounted for 25% of all premium cataract surgeries in Europe during 2023, up from 18% in 2021.
   
• In addition, ophthalmic laser platforms are incorporating artificial intelligence and high-resolution imaging technologies for enhanced accuracy. AI helps in real-time decision-making and customizing treatments based on patient-specific data. This trend is improving surgical planning, reducing errors, and enhancing post-operative recovery.
   
• Owing to the safety profile and effectiveness of the treatment, Selective Laser Trabeculoplasty (SLT) is emerging as the most preferred first-line treatment for glaucoma. Unlike some medications, SLT is free from compliance issues and thus provides long-term care benefits. With increased awareness, ophthalmologists are enthusiastic to recommend SLT as an initial preventive strategy.
   
• Further, manufacturers are working on new compact and lightweight laser systems that are easier to transport and can be installed in smaller clinics. These advances improve the availability of sophisticated treatments in remote and resource-limited areas. Such developments positively grow further the goals of mobile eye care services and geospatial expansion. Thus, the aforementioned factors are expected to drive the market growth positively.
   

Ophthalmic Lasers Market Analysis

Based on the product type, the ophthalmic lasers market is segmented into femtosecond lasers, diode lasers, excimer lasers, Nd:YAG lasers, and other product types. The femtosecond lasers segment has asserted its dominance in the market by securing a significant market share of 36% in 2024 owing to the increasing adoption in cataract and refractive surgeries due to their high precision, safety, and bladeless incision capabilities. Growing demand for premium ophthalmic procedures and improved visual outcomes further accelerates their usage.
 

The segment is expected to exceed USD 1.1 billion by 2034, growing at a CAGR of 6.1% during the forecast period. On the other hand, the diode lasers segment is expected to grow with a CAGR of 6.6%. The growth of this segment can be attributed to their cost-effectiveness, portability, and widespread use in retinal photocoagulation and glaucoma treatment, especially in low-resource settings. Their compact design and ease of use make them ideal for outreach programs and emerging markets.
 

• The femtosecond lasers segment continues to dominate the market owing to their increased use in cataract and refractive surgeries. These lasers offer high precision, minimize tissue damage, and enable bladeless incisions. According to the American Society of Cataract and Refractive Surgery (ASCRS), laser-assisted cataract surgeries increased by 35% between 2021 and 2023. These technologies facilitate advanced procedures such as laser-assisted cataract surgeries (LACS) and LASIK, leading to better results in patient recovery and overall shorter recovery times.
   
• In addition, the U.S. Centers for Disease Control and Prevention (CDC) estimated that cataracts affected over 24.4 million Americans aged 40 and above in 2023, driving the demand for premium intraocular lens (IOL) implantation.
   
• The European Society of Cataract and Refractive Surgeons (ESCRS) reported that the adoption of femtosecond lasers in Europe increased by 42% from 2022 to 2024. The blending of femtosecond lasers and real-time imaging increased the accuracy of surgery, and the American Academy of Ophthalmology reported a 28% decrease in post-surgical complications in 2023 as compared to older methods.
   
• Diode lasers are becoming more widely used owing to their cost-effective eye care devices due to their long lifespan and low maintenance. They are also clinically valuable due to their broad applicability for treating several retinal diseases and performing cyclodestructive surgeries for glaucoma.
   
• The rising prevalence of diabetic retinopathy globally is boosting demand for retinal photocoagulation, where diode lasers are widely used. Additionally, increasing deployment in mobile eye care units supports their expansion in remote and underserved regions.
   
• The excimer lasers segment was valued at USD 327.5 million in 2024 and expected to grow during the forecast period. The segment is fueled by their use for the corneal reshaping in the refractive surgical procedures such as LASIK and PRK owing to the excimer lasers high precision and low thermal damage. The market is also driven by the growing adoption of corrective vision procedures and technological refinements in the profiles of laser ablation.
   
• The Nd:YAG lasers segment was valued at USD 262.5 million in 2024 and expected to grow during the forecast period. Nd:YAG lasers are propelled by the acceptance of posterior capsulotomy and laser iridotomy for the treatment of secondary cataracts and angle-closure glaucoma. These non-invasive procedures are performed in a timely manner, do not require hospitalization, and are done on an outpatient basis, which makes them readily available for routine eye care.
   

Based on technology, the ophthalmic lasers market is segmented as photocoagulation, photodisruption, ablation, and other technologies. The photocoagulation segment dominated the market in 2024 accounting for USD 738.4 million and is anticipated to grow at a CAGR of 5.6% during the forecast period.
 

• The key factors driving the adoption of photocoagulation technology in the ophthalmic lasers market are the increasing occurrence of retinal disorders like diabetic retinopathy, retinal vein occlusion, and age-related macular degeneration. With the global rise in the diabetic population, there are more cases of diabetic-associated retinal complications, which need prompt action. Photocoagulation is an effective way to manage these complications. It is a non-invasive procedure and has a proven track record of clinically efficacious sealing of leaking blood vessels to prevent further retinal complications.
   
• Further, the development of other technologies, including laser pattern scanning, has increased overall treatment efficiency and has made the treatment safer, which ophthalmologists have embraced. Increased outpatient procedure requests along with the need for lower-priced treatments have also boosted the adoption of photocoagulation in developing and developed countries.
   
• The photodisruption segment was valued at USD 530.1 million in 2024 and expected to grow during the forecast period. The segmental growth is attributed to the higher adoption of non-invasive and accurate surgical techniques to treat posterior capsular opacification (PCO), glaucoma, and refractive errors. The application of Nd:YAG lasers in posterior capsulotomy and peripheral iridotomy procedures has become standard practice because these lasers provide contained energy delivery, preserving surrounding tissues.
   
• The trend toward premium intraocular lenses (IOLs) following cataract surgery has also increased the need for secondary interventions using photodisruptive lasers. Furthermore, the growing preference for outpatient laser procedures and shorter recovery times is accelerating the adoption of photodisruption techniques across eye care centers globally.
   
• The ablation segment is expected to grow at the fastest rate of 6.5% over the forecast period. Ablation technologies are propelled by their ability to remove corneal tissues with accuracy for the treatment of refractive errors such as myopia, hyperopia, and astigmatism. The increasing need for customized vision correction procedures and sophisticated laser ablation profiles is driving their use in ophthalmic procedures.
   

Based on application, the ophthalmic lasers market is segmented as refractive error correction, cataract surgery, diabetic retinopathy, glaucoma, and other applications. The refractive error correction segment dominated the market in 2024 accounting for USD 611.5 million and is anticipated to grow at a CAGR of 5.2% during the forecast period.
 

• The global burden of myopia, hyperopia, and astigmatism, especially within the younger and working-age demographics, continues to accelerate. This shift is driven by changes in lifestyle, such as increased screen time and reduced outdoor activities. There is a growing persistent need for refractive error correction in the ophthalmic lasers market.
   
• As a result, there is a growing adoption of LASIK, PRK, and SMILE procedures, as they provide long-term vision enhancement without the need for eyeglasses or contacts. Along with greater awareness, the adoption of advanced excimer and femtosecond lasers is more readily available and affordable, which accelerates market growth. Another factor driving the market is the ease and cosmetic appeal of spectacle-free vision, which continues to attract a large consumer base seeking elective refractive surgeries.
   
• The cataract surgery segment holds the second position in the application segment and is anticipated to grow at a CAGR of 6.8% over the forecast period. The growth of the segment is supported by the rapidly aging world population, as cataracts are common in people over 60 years of age. There is an increasing adoption of laser-assisted cataract surgery (LACS) which is a more sophisticated method of performing lens fragmentation, capsulotomy, and corneal incisions than the traditional approach. This technique reduces surgical complications, improves visual outcomes, and supports quicker recovery.
   
• In addition, the rising need for complex intraocular lenses (IOLs) which improve vision by correcting cataracts and enhancing precision in lasers for LACS, is also a driving factor. LACS is also supported by government programs and increasing healthcare resources in developing countries which ensures wider availability for advanced cataract surgeries.
   
• The diabetic retinopathy segment was valued at USD 310.9 million in 2024 and expected to grow during the forecast period. Growth in this segment is supported by the increasing prevalence of diabetes across the globe, along with timely intervention, retinovascular surgery, and targeted intervention to prevent vision impairment. Laser photocoagulation remains the standard treatment owing to its cost-effectiveness in the public health system especially in the emerging markets.
   
• The glaucoma segment was valued at USD 233.1 million in 2024 and expected to grow during the forecast period. The glaucoma segment is propelled by increasing adoption of laser-based therapies like SLT and ALT as first-line treatments, reducing dependence on long-term medications. Growing awareness, early diagnosis, and the shift toward outpatient laser procedures further enhance market demand.

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, the ophthalmic lasers market is classified into hospitals, ophthalmic clinics, ambulatory surgical centers, and other end users. The hospitals segment dominated the market with a revenue share of 51.1% in 2024 owing to the high patient volume and specialized eye care services, availability of skilled ophthalmologists and support staff, growing preference for in-house laser procedures, among others factors.
 

• The top three end use segments account for over 94% of the total market value, with hospitals leading as the highest segment due to the complex and large volume, high-risk patient base, often times also including diverse and challenging ophthalmic cases. Comprehensive, integrated, multi-disciplinary, and value-added services tailored under one roof make the hospitals the primary and preferred providers for laser-based eye treatments. This concentration of specialized services spurs demand for advanced ophthalmic laser systems in the hospitals.
   
• The hospitals attract and recruit trained ophthalmic surgeons and clinical staff with experience, enabling the effective application of laser technologies. The presence of skilled personnel readily available makes it easy to guarantee a precise clinical diagnosis, treatment plan, and safe execution of critical procedures, increasing the willingness to invest in the sophisticated laser systems within the hospital infrastructure.
• Further, many hospitals are integrating laser platforms into their ophthalmology departments to perform procedures on-site, reducing the need for patient referrals to external laser centers. This in-house capability enhances patient retention, improves turnaround time, and ensures continuity of care, thus supporting the use of ophthalmic lasers.
   
• The ophthalmic clinics segment has captured the second position in the end-use segment and is expected to grow at a CAGR of 6.4% during the forecast period. Ophthalmic clinics are a key end-user segment due to their high procedure volumes, specialization in laser eye surgeries, and quicker patient turnaround times. The growing preference for outpatient care and availability of compact, clinic-friendly laser systems support their expanding role in the market.
   
• The ambulatory surgical centers segment was valued at USD 305.7 million and is expected to witness a steady growth in the forecast period. These centers are increasingly becoming prominent in the ophthalmic lasers market because of their cost-effective approach, quick recovery time, and high volume of laser procedures performed. The increase in same-day procedures and favorable reimbursement policies are additional drivers of laser utilization in these facilities.

North America dominated the global ophthalmic lasers market with the highest market share of 39% in 2024.
 

• The U.S. ophthalmic lasers market was valued at USD 598.3 million and USD 617.4 million in 2021 and 2022, respectively. The market size reached USD 658.6 million in 2024, growing from USD 637.5 million in 2023 and is anticipated to grow at a CAGR of 5.4% between 2025 to 2034 period.
   
• North America, particularly the U.S., has a significant elderly population susceptible to eye conditions such as cataracts, glaucoma, and age-related macular degeneration. According to the U.S. Census Bureau, the population aged 65 and older is anticipated to reach 77 million by 2023. The rising prevalence of diabetes contributes to higher rates of diabetic retinopathy. This expanding patient population creates consistent demand for ophthalmic laser procedures across surgical and outpatient facilities.
   
• The outpatient and surgical centers in the region continue to gain from the robust healthcare system alongside strong regional patient coverage to specialized ophthalmic practitioners. Favorable reimbursement policies regarding laser procedures to be undertaken and other diagnostic procedures translate to low patient payments, increasing the volume of procedures performed, and adoption of laser technologies.
   
• North America is home to several leading manufacturers and early adopters of cutting-edge ophthalmic laser technologies, including femtosecond and excimer lasers. The rapid integration of AI, image-guided systems, and minimally invasive tools into ophthalmic practices supports continuous upgrades and high equipment turnover in the region.
   
• Further, the rising popularity of LASIK, SMILE, and other vision correction procedures are increasing the need for advanced laser technologies. Additionally, urban and suburban markets are expanding as consumers with higher disposable incomes are more informed and are shifting towards spectacle-free living, resulting in heightened interest in elective procedures.
   

Europe ophthalmic lasers market accounted for USD 521.1 million in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• The European market is supported by preventative eye care and early diagnosis due to national healthcare systems and public health initiatives. Several European countries have vision screening programs for the elderly and diabetic population, which has improved the identification of diabetic retinopathy and glaucoma.
   
• The public hospitals as well as the specialized clinics are investing into modern equipment driven by the EU standards which is increasing the efficiency of the procedures. In addition, the public awareness of laser treatment services are advancing, thus driving the spending towards modern laser ophthalmic equipment. This drives the ever increasing public and private investment and modernization of EU-conform laser ophthalmic equipment.
   
• Another key driver in Europe is the adoption of laser technology in healthcare private clinics is attributed to the growing popularity of bladeless cataract surgeries, excimer laser refractive surgery, as well as the rapid recovery periods associated with these procedures. Due to growing patient demand, the femtosecond and excimer lasers are being more frequently used in private clinics.
   
• Additionally, the expansion of medical tourism in countries like Germany, Hungary, and Turkey, where patients seek high-quality eye treatments at competitive prices, is further stimulating market growth. The region's strong regulatory environment also plays a role by ensuring safety and performance of laser technologies, encouraging wider acceptance among healthcare providers and patients alike.
   

The Asia Pacific ophthalmic lasers market is anticipated to grow at the highest CAGR of 7.1% during the analysis timeframe.
 

• The  regional market is being driven by the rapidly growing burden of vision-related disorders, especially due to the rising prevalence of diabetes, myopia, and cataracts. Countries such as China and India are experiencing a surge in lifestyle-related eye conditions, primarily due to urbanization, aging populations, and increased screen exposure among youth.
   
• The public health and ophthalmology sectors are responding to the gaps in the vision care market with comprehensive, affordable eye care which is expanding national screening and public eye health campaigns. Accelerated vision care, along with the focus on treating conditions at their root with non-invasive laser diagnostics, is in demand in rural and urban regions.
   
• In addition, the market is gaining from increasing investments in the healthcare industry as well as the growing private practice ophthalmology centers that provide sophisticated laser procedures. Patients from the Asia Pacific region are now more willing to undergo laser eye surgeries like LASIK or femtosecond cataract surgeries because of better results and increased awareness coupled with lower prices.
   
• Medical tourism is also a major contributor to growth, especially in Thailand, India, and South Korea, which are known to provide affordable laser eye surgeries of world-class standards. Domestic and international practitioners are taking advantage of this opportunity by manufacturing portable, affordable laser machines specifically designed for emerging economies, fostering greater acceptance in the region.
   

The Latin America ophthalmic lasers market is experiencing robust growth over the analysis timeframe.
 

• In Latin America, the ophthalmic lasers market is primarily driven by a growing incidence of preventable and treatable eye diseases such as cataracts, diabetic retinopathy, and glaucoma. A large portion of the region’s population remains underserved in terms of specialized eye care, especially in rural and semi-urban areas.
   
• Non-governmental and governmental organizations actively promote and provide public laser treatment facilities in mobile clinics and public hospitals. As the treatment campaigns broaden, the need for deployment in low-resource settings, in portable and affordable ophthalmic laser systems, is also increasing.
   
• Moreover, the rising investment in private healthcare infrastructure and the emergence of specialized ophthalmic centers in major Latin American cities. Middle-class populations in countries like Brazil, Mexico, and Colombia are showing a growing preference for elective procedures such as LASIK and photorefractive keratectomy (PRK), driven by increasing disposable income and interest in vision correction.
   
• Additionally, eye treatment is the most sought-after service for patients traveling to Latin America for medical tourism, making the region a prime candidate for lower eye treatment costs. In the public and private sectors, the advanced ophthalmic laser technology is rapidly penetrating the region in reaction to the region-specific solutions and training programs manufacturers are introducing.
   

Ophthalmic Lasers Market Share

• global ophthalmic lasers market is moderately consolidated, with a few major players holding a significant share of the global market. Key players such as Alcon, Johnson & Johnson, ZEISS, LUMENIS, and NIDEK collectively account for 59.3% of the total market. These companies have established strong brand recognition, global distribution networks, and a broad portfolio of laser technologies catering to cataract surgery, refractive error correction, glaucoma treatment, and retinal disorders. Their competitive edge is further reinforced by continuous investments in research and development, clinical validation, and collaborations with ophthalmic surgeons and institutions.
   

Smaller players and regional manufacturers are also emerging with niche solutions, particularly in cost-sensitive markets across Asia-Pacific and Latin America. While they may not match the scale of global leaders, these companies often offer portable and affordable laser systems that meet local needs.
 

Technological innovation, product differentiation, and regional regulatory compliance are key factors shaping the competitive dynamics. Strategic moves such as mergers, acquisitions, and product launches are common as companies aim to expand their geographic presence and strengthen their position in specific ophthalmic applications.
 

Ophthalmic Lasers Market Companies

Few of the prominent players operating in the ophthalmic lasers industry include:

• A.R.C. LASER
• Alcon
• BAUSCH + LOMB
• Glaukos
• IRIDEX
• Johnson & Johnson
• LIGHTMED
• LUMENIS
• LUMIBIRD MEDICAL
• Meridian Medical
• NIDEK
• TOPCON Healthcare
• ZEISS
• Ziemer Ophthalmology
   
• Alcon

Alcon leads the ophthalmic lasers market with a share of 18.2% in 2024. Alcon offers one of the most comprehensive portfolios in ophthalmic lasers, including the LenSx femtosecond laser system for cataract surgery and PurePoint laser for retina. Its strong global distribution network, integration with premium intraocular lenses (IOLs), and leadership in both refractive and cataract surgery segments make it a dominant player.
 

• Johnson & Johnson

Johnson & Johnson stands out with its iFS Advanced Femtosecond Laser and VISX STAR S4 IR Excimer Laser System, widely used in LASIK and other refractive procedures. The company leverages deep clinical research, surgeon training programs, and bundled solutions across surgical and vision care to maintain a strong foothold.
 

• ZEISS

ZEISS is known for its cutting-edge VisuMax femtosecond laser and its pioneering role in SMILE (Small Incision Lenticule Extraction), a minimally invasive alternative to LASIK. Its vertical integration with diagnostics, surgical microscopes, and laser platforms delivers unmatched workflow efficiency and precision for ophthalmic surgeons.
 

Ophthalmic Lasers Industry News:

• In April 2025, BVI Medical received 510(k) clearance from the U.S. FDA for its Leos (Laser Endoscopy Ophthalmic System), a minimally invasive glaucoma surgical platform. Leos is the only laser system that lowers intraocular pressure by targeting aqueous humor production via an ab interno approach. It features advanced endoscopic visualization, enhancing surgical precision. This innovation is set to boost adoption of laser-based MIGS procedures in glaucoma care.
   
• In January 2025, Norlase received FDA 510(k) clearance and CE Mark for its LYNX, the world’s first battery-powered pattern scanning laser indirect ophthalmoscope. The device, fully integrated into an ergonomic headset, eliminated the need for external laser sources. Its wireless interface and voice control improved surgical mobility and efficiency. This breakthrough is expected to boost ophthalmic laser adoption, particularly in outpatient and mobile care settings.
   
• In August 2024, Meridian received FDA approval for its MR Q family of lasers, including the MR Q, MR Q SLT, and MR Q Supine systems, designed for diverse ophthalmic procedures. This followed an earlier FDA clearance for the Merilas laser line, which covers photocoagulation and glaucoma therapies. These approvals have expanded Meridian’s advanced laser offerings and are expected to boost its market presence and support wider adoption in ophthalmic care.
   
• In January 2024, Iridex Corp. launched its next-generation Iridex 532 and Iridex 577 lasers in the U.S., featuring multiple treatment modes, including continuous-wave and patented MicroPulse Technology. The systems also included an intuitive touchscreen and advanced control options. These upgrades enhanced precision and versatility in treating retinal disorders and glaucoma. The launch is expected to drive adoption of advanced laser therapies in ophthalmic care.
   

The ophthalmic lasers market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 - 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Femtosecond lasers
• Diode lasers
• Excimer lasers
• Nd:YAG lasers
• Other product types

Market, By Technology

• Photocoagulation
• Photodisruption
• Ablation
• Other technologies

Market, By Application

• Refractive error correction
• Cataract surgery
• Diabetic retinopathy
• Glaucoma
• Other applications

Market, By End Use

• Hospitals
• Ophthalmic clinics
• Ambulatory surgical centers
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE